INTERNATIONAL PATENT: URSAPHARM ARZNEIMITTEL GMBH FILES APPLICATION FOR "OPHTHALMOLOGICAL COMPOSITION CONTAINING AT LEAST ONE NICOTINIC ACETYLCHOLINE RECEPTOR MODULATOR FOR TOPICAL ADMINISTRATION TO THE EYE FOR PREVENTING OR TREATING INFLAMMATION OF THE EYE"

GENEVA, March 3 -- URSAPHARM ARZNEIMITTEL GMBH (Industriestrasse 3566129 Saarbrucken) filed a patent application (PCT/EP2024/073158) for "OPHTHALMOLOGICAL COMPOSITION CONTAINING AT LEAST ONE NICOTINIC ACETYLCHOLINE RECEPTOR MODULATOR FOR TOPICAL ADMINISTRATION TO THE EYE FOR PREVENTING OR TREATING INFLAMMATION OF THE EYE" on Aug 16, 2024. With publication no. WO/2025/040605, the details related to the patent application was published on Feb 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): STEINFELD, Ute (Reichenbrunnerstr. 55b66386 St. Ingbert), LEE, Hyeck Hee (Im kurzen Tal 866386 St. In...